Biogenerics, e-prescribing top PCMA 2007 policy agenda

March 5, 2007

Preserving PBMs' cost-saving model in Medicare Part D, creating a legal pathway for biogenerics, and adopting a national uniform e-prescribing standard are among the issues that top PCMA's policy agenda for 2007, according to president Mark Merritt, who announced the new initiative. "At a time when policymakers in Washington are looking for real-world solutions, PCMA has put forward a pro-consumer agenda to improve health care, but without billions of dollars in new federal spending," he said. "We urge policymakers to build on this model in 2007. PCMA's policy agenda is unique in that it would improve the healthcare system and save consumers, employers, and taxpayers tens of billions of dollars." Other key issues PCMA promises to address in 2007 include: removing barriers and expanding access to conventional generics; promoting value-based purchasing through comparative effectiveness; and opposing proposals, such as a one-size-fits-all disclosure, that would result in increased costs for consumers and private and public payers with no corresponding benefit.

To see more Hot off the Press news articles, click here.

To go to the Drug Topics homepage, click here.